T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza

NCT01728753 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2015-10-21

No results posted yet for this study

Summary

This is safety and pharmacokinetics (PK) of favipiravir study in adults 18-80 years of age diagnosed with uncomplicated influenza.

Conditions

Interventions

DRUG

Placebo

Placebo BID x 1 day, and Placebo BID x 4 days; Placebo TID x 1 day, and Placebo TID x 4 days

DRUG

Favipiravir

1200 mg TID on Day 1, then 600 mg TID on Days 2-5

DRUG

Favipiravir

2400 mg loading dose followed by 600 mg + 600 mg on Day 1, then 600 mg TID on Days 2-5

DRUG

Favipiravir

1800 mg BID on Day 1, then 800mg BID for Days 2 5

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • MDVI, LLC

    lead INDUSTRY

Principal Investigators

  • Jason M Hafizullah, MD · Sunrise Medical Research, Lauderdale Lakes, FL 33319

  • Susan Hole, D.O. · Riverside Clinical Research, Edgewater, FL 32132

  • Richard L. Beasley, MD · Health Concepts, Rapid City, SD 57702

  • Jay H Sandberg, DO · Oakland Medical Research Center, Troy, MI 48085

  • Edgardo A. Osea, MD · Holy Trinity Medical Clinic, Harbor City, CA 90710

  • Shawn N. Gentry, MD · HCCA Clinical Research Solutions, Columbia, TN 38401

  • Stephen K. Smith, MD · Burke Primary Care, Morganton, NC 28655

  • Roberto Sotolongo, MD · Research Institute of South Florida, Inc., Miami, FL 33173

  • Marina Raikhel, MD · Torrance Clinical Research Institute Inc., Lomita, CA 90717

  • Syed M. Rehman, MD · Asthma & Allergy Center, Toledo, OH 43617

  • Jeffrey Lenz, MD · Integrated Clinca Trial Services Inc., West Des Moines, IA 50265

  • Jorge L. Santander, MD · APF Research LLC, Miami, FL 33135

  • James A. Cervantes, MD · Meridian Clinical Research, Bellevue, NE 68005

  • Hipolito G. Mariano Jr., MD · Research Center of Fresno, Inc., Fresno, CA 93726

  • John M. Wise, MD · Field of Dreams PC, dba Bozeman Urgent Care Center, Bozeman, MT 59715

  • Mercedes B. Samson, MD · Associated Pharmaceutical Research Center, Inc., Buena Park, CA 90620

  • Shaukat A. Shah, MD · St. Joseph's Medical Associates, Stockton, CA 95204

  • Darin Gregory, MD · Pioneer Clinical Research LLC, Bellevue, NE 68005

  • Sandra M. Gawchik, DO · Asthma and Allergy Research Associates, Upland, PA 19013

  • Tiffany M. Pluto, DO · Fay West Family Practice, Scottdale, PA 15683

  • Rennee N. Dhillon, MD · HCCA Clinical Research Solutions, Franklin, TN 37067

  • Almena L. Free, MD · Pinnacle Research Group LLC, Anniston, AL 36207

  • Esperanza Arce-Nunez, MD · South Florida Research Phase I-IV, Inc., Miami, FL 33165

  • Robert D. Rosen, MD · Clinical Trials of America, Inc., Winston Salem, NC 27103

  • Charles M. Schwarz, MD · Lovelace Scientific Resources, Inc., Venice, FL 34292

  • Idalia A. Acosta, MD · San Marcus Research Clinic Inc., Miami, FL 33015

  • Kishor E. Joshi, MD · Cherry Tree Medical Associates/Alternative Clinical Trials LLC, Uniontown, PA 15401

  • Patricia D. Salvato, MD · Diversified Medical Practices, P.A., Houston, TX 77057

  • Lawrence P. Schwartz, MD · HCCA Clinical Research Solutions, New York, NY 10016

  • Michael C. Hagan, MD · Montana Health Research Institute Inc., Billings, MT 59102

  • Martin J. Schear, MD · Dayton Clinical Research, Dayton, OH 45406

  • Stephen Ong, MD · MD Medical Research, Oxon Hill, MD 20745

  • April Palmer, MD · Clinical Trials Of America Inc., Shreveport, LA 71105

  • Derek D. Muse, MD · Highland Clinical Research, Salt Lake City, UT 84124

  • Jose M. Carpio, MD · The Community Research of South Florida, Hialeah, FL 33016

  • Thomas M Birch, MD · Holy Name Medical Center, Teaneck, NJ 07666

  • Barry K McLean, MD · Cahaba Research, Birmingham, AL 35242

  • Barry N Heller, MD · Novo Research Inc., Highland Heights, KY 41076

  • Karl V Sitz, MD · Little Rock Allergy & Asthma Clinical Research Center, Little Rock, AR 72205

  • Thomas C Nilsson, MD · Midwest Allergy and Asthma Clinic, P.C., Omaha, NE 68130

  • Douglas W Mapel, MD · Clinical Trial Connection, Flagstaff, AZ 86001

  • Ronald G DeGarmo, DO · DeGarmo Institute of Medical Research, Greer, SC 29651

  • Teresa S Sligh, MD · Providence Clinical Research, North Hollywood, CA 91606

  • Gary L Sutter, MD · HealthCare Partners Medical Group LLC, Los Angeles, CA 90015

  • John P Delgado, MD · Integrated Medical Research, PC, Ashland, Oregon 97520

  • Ronald K Stegemoller, MD · American Health Network of IN, LLC, Avon, IN 46123

  • Edgar A Marin, MD · Global Clinical Professionals, Miami, FL 33156

  • Marie R Albert, DO · Acadia Clinical Research, LLC, Bangor, Maine 04401

  • Mark A Turner, MD · Advanced Clinical Research Inc., Meridian, ID 83642

  • Terry L Poling, MD · Heartland Research Associates, LLC, Wichita, KS 67207

  • David R Hassman, DO · Comprehensive Clinical Research, Berlin, NJ 08009

  • William C Simon, DO · Professional Research Network of Kansas, LLC, Wichita, KS 67203

  • Brian K Allen, DO · University of Wisconsin La Crosse, La Crosse, WI 54601

  • Ernest L Hendrix, MD · North Alabama Research Center LLC, Athens, Alabama 35611

  • John A Panuto, MD · HCCA Clinical Research Solutions, Middleburg Heights, OH 44130

  • Sadia Dar, MD · HCCA Clinical Research Solutions, Smyrna, TN 37167

  • Michael E Hodges, MD · North Central Arkansas Medical Associates, Mountain Home, AZ 72653

  • Melanie Hoppers, MD · Physicians Quality Care, Jackson, TN 38305

  • Khai S Chang, MD · Lakeview Medical Research, Summerfield, FL 34491

  • Arles Perdomo, MD · Best Quality Research, Hialeah, FL 33016

  • Neerja Misra, MD · Quick Care Medical, Hamilton, NJ 08690

  • Steve Choi, MD · Urgent Care Specialist, LLC DBA Hometown Urgent Care & Occupational Health, Dayton, OH 45432

  • Gregory Pokrywka, MD · IRC Clinics, Towson, MD 21204

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01728753 on ClinicalTrials.gov